Different risks for NSAID-induced anaphylaxis

Annals of Pharmacotherapy

Volumn 36, Issue 1, 2002, Pages 24-29

  Van Puijenbroek, Eugène P ^a   Egbert, Antoine C G ^b,c   Meyboom, Ronald H B ^d   Leufkens, Hubert G M ^c  

^a Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

^b GGZ Midden Brabant   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

Anaphylaxis; Nonsteroidal antiinflammatory drugs; Pharmacovigilance; Quantitative signal detection

Indexed keywords

DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; AGE; AGED; ANAPHYLAXIS; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG CLASSIFICATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NETHERLANDS; PHARMACISTS; PRODUCT SURVEILLANCE, POSTMARKETING; RISK FACTORS; SEX FACTORS;

EID: 0036143597     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A140     Document Type: Article

References (39)

1. Assessment and treatment of neuropathic cancer pain following WHO guidelines
2. Validation of World Health Organization guidelines for cancer pain relief: A 10-year prospective study
3. Non-steroidal anti-inflammatory drugs
4. A population based case-cohort study of drug-induced anaphylaxis
5. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature
6. Adverse reactions of aspirin and related drugs
7. Ibuprofen urticaria
8. Anaphylaxis from tolmetin
9. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis
10. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs
11. Coronary artery spasm and acute myocardial infarction in naproxen-associated anaphylactic reaction
12. Mechanism of anti-inflammatory action of etodolac
13. Anaphylactic reaction to oral diclofenac sodium sustained-release tablet
14. Nonsteroidal anti-inflammatory intolerance. An anaphylactic reaction to tolmetin
15. Fatal anaphylactic reaction to diclofenac
16. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin
17. Efficacy of diclofenac/misoprostol vs diclofenac in the treatment of ankylosing spondylitis
18. Anaphylactic shock induced by diclofenac
19. Anaphylaxis and coronary disease
20. Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs
21. Adverse drug reactions: Definitions, diagnosis, and management
22. Serum sickness-like reactions to cefaclor
23. Statistical aspects of monitoring for dangers in drug therapy
24. The design and logic of a monitor of drug use
25. A Bayesian neural network method for adverse drug reaction signal generation
26. Non-puerperal lactation associated with antidepressant drug use
27. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: A case/non-case study in the French pharmacovigilance system database
28. Allergy and allergic diseases: Allergic diseases and their treatment
29. Anaphylaxis and anaphylactoid reactions
30. Anaphylaxis
31. Analgesics-antipyretic and antiiflammatory agents and drugs employed in the treatment of gout
32. Immunopathogenetic roles of leukotrienes in human diseases
33. The need for randomization in the study of intended effects
34. An ABC of drug-related problems
35. Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems
36. Risk of anaphylaxis in patients receiving beta-blocker drugs